ImmunityBio, Inc.IBRXNASDAQ
Loading
Interest Expense Over TimeContracting
Percentile Rank92
3Y CAGR+33.6%
5Y CAGR+65.5%
Studio
Year-over-Year Change

Interest expense on outstanding debt

3Y CAGR
+33.6%/yr
vs +223.0%/yr prior
5Y CAGR
+65.5%/yr
Recent deceleration
Acceleration
-189.4pp
Decelerating
Percentile
P92
Near historical high
vs 5Y Ago
12.4x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$112.53M-14.5%
2024$131.66M+51.8%
2023$86.72M+83.9%
2022$47.15M+217.5%
2021$14.85M+63.6%
2020$9.07M+53.3%
2019$5.92M+1267.2%
2018$433000.00-29.9%
2017$618000.00+836.4%
2016$66000.00-